Literature DB >> 22234176

Responsiveness of a patient in a persistent vegetative state after a coma to weekly injections of autologous activated immune cells: a case report.

Barbara Fellerhoff1, Barbara Laumbacher, Rudolf Wank.   

Abstract

INTRODUCTION: An 82-year-old Caucasian woman had remained in a persistent vegetative state after a coma of seven months duration, which occurred after a stroke with hemiplegia, nine years previously. The persistent vegetative state could be reversed in part by weekly injections with activated immune cells. After therapy, our patient responded to commands in addition to regaining spontaneous movements of both arms and the ability to swallow. This is the first report on the treatment with activated immune cells of a patient in a persistent vegetative state after a coma. CASE
PRESENTATION: An 82-year-old Caucasian woman presented with a persistent vegetative state subsequent to a coma. She retained respiratory and autonomic functions. As contact was not possible, physiotherapy was passive. Her skin was yellowish, and our patient did not move by herself. Vomiting repeatedly resulted from tube feeding. After a once-weekly treatment with activated immune cells sampled from our patient's blood and activated in vitro, several of her functions gradually returned. Our patient opened her eyes in the requested direction and turned her head toward people entering the room. She 'supported' nursing efforts, as the nurse noted a loss of spastic motions. The strength in both her arms returned, and she spontaneously moved her arm on the side experiencing hemiplegia. After three months, our patient could stick out her tongue upon demand. Finally, the swallow reflexes of our patient started to return. However, tube feeding was continued, and our patient died after aspiration of vomit following a feeding.
CONCLUSION: The success of treatment with autologous activated immune cells in this patient may have resulted from the production of neuroactive substances, such as neurotrophin-3 and brain-derived neurotrophic factor, by activated immune cells. The deterioration of our patient could be reversed, as demonstrated by the restoration of motor strength in her hemiplegic side. In addition, our patient was able to induce motor responses upon request. It seems reasonable to conclude that activated immune cells may improve the chronic vegetative state in some patients.

Entities:  

Year:  2012        PMID: 22234176      PMCID: PMC3284865          DOI: 10.1186/1752-1947-6-6

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  9 in total

Review 1.  Neurotrophins and their receptors in nerve injury and repair.

Authors:  M Ebadi; R M Bashir; M L Heidrick; F M Hamada; H E Refaey; A Hamed; G Helal; M D Baxi; D R Cerutis; N K Lassi
Journal:  Neurochem Int       Date:  1997 Apr-May       Impact factor: 3.921

2.  Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors.

Authors:  M Besser; R Wank
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

3.  High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy.

Authors:  Barbara Fellerhoff; Barbara Laumbacher; Rudolf Wank
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

4.  Rapid responses of lymphocytes in an optimized mixed lymphocyte culture.

Authors:  R Wank
Journal:  Tissue Antigens       Date:  1982-05

5.  Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity.

Authors:  G Moalem; A Gdalyahu; Y Shani; U Otten; P Lazarovici; I R Cohen; M Schwartz
Journal:  J Autoimmun       Date:  2000-11       Impact factor: 7.094

6.  Activated monocytes prime naïve T cells against autologous cancer: vigorous cancer destruction in vitro and in vivo.

Authors:  B Laumbacher; S Gu; R Wank
Journal:  Scand J Immunol       Date:  2012-03       Impact factor: 3.487

7.  Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors.

Authors:  E S Levine; C F Dreyfus; I B Black; M R Plummer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Schizophrenia and other mental disorders require long-term adoptive immunotherapy.

Authors:  Rudolf Wank
Journal:  Med Hypotheses       Date:  2002-08       Impact factor: 1.538

9.  Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus.

Authors:  A Figurov; L D Pozzo-Miller; P Olafsson; T Wang; B Lu
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

  9 in total
  1 in total

Review 1.  Music in Research and Rehabilitation of Disorders of Consciousness: Psychological and Neurophysiological Foundations.

Authors:  Boris Kotchoubey; Yuri G Pavlov; Boris Kleber
Journal:  Front Psychol       Date:  2015-11-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.